HIV Prevention Research, Development and Implementation Pipeline in 2020—and Beyond

The graphic below shows the wide range of HIV prevention and multipurpose prevention products (MPTs) available and in the pipeline. Products that are “in development” are, for the most part, many years away from regulatory consideration and wide-scale introduction. The exception: combined oral PrEP and oral contraceptives, which could be ready in two to three years, at least five years before the next MPT might come to market.

Excerpted from AVAC Report 2019: Now What?